CMS is adding two postprocedural breast diagnoses to its mammography coverage coding. Breast-imaging and revenue-cycle teams should prepare now for the codes and their separate effective dates….
FDA has proposed moving digital breast tomosynthesis systems from Class III to Class II. Here is what the change could mean for manufacturers and mammography facilities—and what would remain unchanged….
FDA’s latest MQSA scorecard shows DBT at nearly 95% of certified mammography facilities, more than 44.8 million annual procedures and strong inspection compliance nationwide….